1. The Yale Nature Long COVID Findings (Klein et al., 2023)
In late 2023, a landmark multi-omics investigation published in Nature by Dr. Akiko Iwasaki's laboratory at Yale University (PMID: 37748514) analyzed extensive immune and hormonal parameters in Long COVID.
Using machine learning algorithms to isolate distinguishing disease features, low circulating cortisol was identified as the #1 predictive biomarker separating patients from uninfected and recovered controls. Cortisol levels in patients were approximately half of normal baseline values, confirming decades of earlier ME/CFS endocrinology research by Dr. Anthony Cleare and Dr. Mark Demitrack.
2. Central Hypothalamic Blunting vs. Adrenal Failure
When synthetic Adrenocorticotropic Hormone (ACTH / Cortrosyn) is administered to ME/CFS patients during a Cosyntropin stimulation test, the adrenal glands typically respond vigorously, demonstrating that the adrenal cortex is structurally sound.
The defect lies upstream in the paraventricular nucleus (PVN) of the hypothalamus:
- Cytokine-Mediated Downregulation: Chronic elevated IL-1beta and IL-6 alter hippocampal glucocorticoid receptor sensitivity, causing negative feedback arrest.
- Flattened Diurnal Curve: The healthy Cortisol Awakening Response (CAR)—where cortisol surges by 50% within 30 minutes of waking—is severely flattened, leaving patients incapable of mobilizing metabolic energy in the morning.
3. Clinical Management & Cautions
High-dose synthetic corticosteroids (e.g. Prednisone 20–40 mg) are dangerous in ME/CFS because they suppress adrenal function completely and induce secondary osteoporosis and immunosuppression. Experienced clinicians utilize gentle physiological support:
- Low-Dose Hydrocortisone: In select cases with documented severe hypocortisolism, micro-doses of hydrocortisone (5 mg to 10 mg upon waking, 2.5 mg at noon, mimicking physiological production) under strict endocrinological supervision.
- Circadian Light Therapy: Morning exposure to 10,000 lux broad-spectrum light to stimulate suprachiasmatic nucleus signaling to the pituitary gland.
- Phosphorylated Serine (Phosphatidylserine): For patients with inverted evening cortisol surges that prevent deep stage 3/4 slow-wave sleep.
Peer-Reviewed References
- Klein J, Iwasaki A, et al. Distinguishing features of Long COVID identified through immune profiling. Nature. 2023;623(7985):139-148. PMID: 37748514.
- Cleare AJ, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Lancet. 1999;353(9151):455-458. PMID: 10022718.
- Demitrack MA, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 1991;73(6):1224-1234. PMID: 1658155.